Background and purpose: Natural history studies in spinal muscular atrophy (SMA) have primarily focused on infants and children. Natural history studies encompassing all age groups and SMA types are important for the interpretation of treatment effects of recently introduced survival motor neuron gene-augmenting therapies. Methods: We conducted a cross-sectional study to investigate muscle strength, Hammersmith Functional Motor Scale (Expanded) score and the patterns of muscle weakness in relation to age and SMA type. Results: We included 180 patients with SMA types 1–4 in the age range 1–77.5 years with median disease duration of 18 (range 0–65.8) years. With the exception of the early phases of disease in which children with SMA types 2 a...
OBJECTIVE: To characterize the natural history of spinal muscular atrophy (SMA) over 24 months using...
peer reviewedSpinal muscular atrophy (SMA) is a monogenic disorder caused by loss of function mutati...
OBJECTIVE: To characterize the natural history of spinal muscular atrophy (SMA) over 24 months using...
Background and purposeNatural history studies in spinal muscular atrophy (SMA) have primarily focuse...
Background and purposeNatural history studies in spinal muscular atrophy (SMA) have primarily focuse...
Background and purposeNatural history studies in spinal muscular atrophy (SMA) have primarily focuse...
Background and purposeNatural history studies in spinal muscular atrophy (SMA) have primarily focuse...
Background and purposeNatural history studies in spinal muscular atrophy (SMA) have primarily focuse...
Hereditary proximal spinal muscular atrophy (SMA) is a severe hereditary neuromuscular disorder, whi...
Contains fulltext : 69266.pdf (publisher's version ) (Closed access)BACKGROUND: Sp...
BACKGROUND AND OBJECTIVES Spinal muscular atrophy (SMA) is a progressive neuromuscular disorder a...
BACKGROUND AND OBJECTIVES Spinal muscular atrophy (SMA) is a progressive neuromuscular disorder a...
BACKGROUND: Spinal muscular atrophy (SMA) is caused by a homozygous deletion of the survival motor n...
<div><p>Spinal muscular atrophy (SMA) is a monogenic disorder caused by loss of function mutations i...
We have established the first prospective, collaborative study of spinal muscular atrophy, the secon...
OBJECTIVE: To characterize the natural history of spinal muscular atrophy (SMA) over 24 months using...
peer reviewedSpinal muscular atrophy (SMA) is a monogenic disorder caused by loss of function mutati...
OBJECTIVE: To characterize the natural history of spinal muscular atrophy (SMA) over 24 months using...
Background and purposeNatural history studies in spinal muscular atrophy (SMA) have primarily focuse...
Background and purposeNatural history studies in spinal muscular atrophy (SMA) have primarily focuse...
Background and purposeNatural history studies in spinal muscular atrophy (SMA) have primarily focuse...
Background and purposeNatural history studies in spinal muscular atrophy (SMA) have primarily focuse...
Background and purposeNatural history studies in spinal muscular atrophy (SMA) have primarily focuse...
Hereditary proximal spinal muscular atrophy (SMA) is a severe hereditary neuromuscular disorder, whi...
Contains fulltext : 69266.pdf (publisher's version ) (Closed access)BACKGROUND: Sp...
BACKGROUND AND OBJECTIVES Spinal muscular atrophy (SMA) is a progressive neuromuscular disorder a...
BACKGROUND AND OBJECTIVES Spinal muscular atrophy (SMA) is a progressive neuromuscular disorder a...
BACKGROUND: Spinal muscular atrophy (SMA) is caused by a homozygous deletion of the survival motor n...
<div><p>Spinal muscular atrophy (SMA) is a monogenic disorder caused by loss of function mutations i...
We have established the first prospective, collaborative study of spinal muscular atrophy, the secon...
OBJECTIVE: To characterize the natural history of spinal muscular atrophy (SMA) over 24 months using...
peer reviewedSpinal muscular atrophy (SMA) is a monogenic disorder caused by loss of function mutati...
OBJECTIVE: To characterize the natural history of spinal muscular atrophy (SMA) over 24 months using...